Concepedia

Author

Jan Neelissen

AstraZeneca (Sweden)

Also Known As

J A M Neelissen, J. A. M. NEELISSEN, J. A. M. Neelissen, J. A. Neelissen, J. Neelissen, Jan A. M. Neelissen, Jan A.M Neelissen, Jan A.M. Neelissen, Jan Neelissen

26

Publications

982

Citations

14

H-Index

69

Concepts

All Affiliations

AstraZeneca (Sweden)AstraZeneca (United Kingdom)Karolinska InstitutetLund University
JN

About

Jan Neelissen is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

752

2

Engineering

4

4

207

3

Anesthesia

3

3

110

4

Social Sciences

2

2

160

5

Natural Sciences

1

1

139

Jan Neelissen

×

14

Publications

952

Citations

14

H-Index

YearCitations

Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines

Stefan von Berg, Margareta Bergh, Sven Hellberg,

Journal of Medicinal Chemistry

2012

145

Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand

Anders Juréus, Britt‐Marie Swahn, Johan Sandell,

Journal of Neurochemistry

2010

139

Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds

Anna-Karin Sohlenius-Sternbeck, Lovisa Afzelius, Peteris Prūsis,

Xenobiotica

2010

127

AZD2184: a radioligand for sensitive detection of β‐amyloid deposits

Allan E. Johnson, Fredrik Jeppsson, Johan Sandell,

Journal of Neurochemistry

2008

120

<scp>AZD</scp>1080, a novel <scp>GSK</scp>3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans

Biljana Georgievska, Johan Sandin, James Doherty,

Journal of Neurochemistry

2013

116

The effect of rheological behaviour of a topical anaesthetic formulation on the release and permeation rates of the active compound

Katayoun Welin-Berger, Jan Neelissen, Björn Bergenståhl

European Journal of Pharmaceutical Sciences

2001

78

Aminoimidazoles as BACE-1 inhibitors: The challenge to achieve in vivo brain efficacy

Britt‐Marie Swahn, Jörg Holenz, Jacob Kihlström,

Bioorganic & Medicinal Chemistry Letters

2012

48

Revisiting the peripheral sink hypothesis: inhibiting <scp>BACE</scp>1 activity in the periphery does not alter β‐amyloid levels in the <scp>CNS</scp>

Biljana Georgievska, Susanne Gustavsson, Johan Lundkvist,

Journal of Neurochemistry

2014

44

Rainbow trout corpuscles of Stannius: stanniocalcin synthesis in vitro

Gert Flik, Teresa Labedz, Jan Neelissen,

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

1990

32

Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for β-amyloid plaques

Britt‐Marie Swahn, David Wensbo, Johan Sandell,

Bioorganic & Medicinal Chemistry Letters

2010

30

Page 1